These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 21551268)

  • 1. The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension.
    Esler M
    Exp Physiol; 2011 Jul; 96(7):611-22. PubMed ID: 21551268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sympathetic nervous system in hypertension: back to the future?
    Esler M
    Curr Hypertens Rep; 2015 Feb; 17(2):11. PubMed ID: 25680900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management.
    Esler M
    J Appl Physiol (1985); 2010 Feb; 108(2):227-37. PubMed ID: 19940096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice.
    Esler M; Lambert G; Brunner-La Rocca HP; Vaddadi G; Kaye D
    Acta Physiol Scand; 2003 Mar; 177(3):275-84. PubMed ID: 12608997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses.
    Esler M
    Pharmacol Toxicol; 1993 Nov; 73(5):243-53. PubMed ID: 8115306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of sympathetic nervous system activity in heart failure: the role of norepinephrine kinetics.
    Esler M; Kaye D
    Heart Fail Rev; 2000 Mar; 5(1):17-25. PubMed ID: 16228913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nervous system activation in essential hypertension, cardiac failure and psychosomatic heart disease.
    Esler M; Kaye D
    J Cardiovasc Pharmacol; 2000; 35(7 Suppl 4):S1-7. PubMed ID: 11346214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma noradrenaline kinetics in humans.
    Esler M; Willett I; Leonard P; Hasking G; Johns J; Little P; Jennings G
    J Auton Nerv Syst; 1984 Sep; 11(2):125-44. PubMed ID: 6386942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of elevated heart rate as a sympathetic nervous system biomarker in essential hypertension.
    Esler M; Lambert G; Esler D; Ika Sari C; Guo L; Jennings G
    J Hypertens; 2020 Aug; 38(8):1488-1495. PubMed ID: 32195820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension.
    Esler M; Jennings G; Korner P; Blombery P; Burke F; Willett I; Leonard P
    Clin Exp Hypertens A; 1984; 6(1-2):507-21. PubMed ID: 6697562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenaline spillover and microneurography measurements in patients with primary hypertension.
    Jennings GL
    J Hypertens Suppl; 1998 Aug; 16(3):S35-8. PubMed ID: 9747908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension.
    Esler M
    Hypertension; 2014 Mar; 63(3):e25-32. PubMed ID: 24420544
    [No Abstract]   [Full Text] [Related]  

  • 16. High blood pressure management: potential benefits of I1 agents.
    Esler M
    J Hypertens Suppl; 1998 Aug; 16(3):S19-24. PubMed ID: 9747906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of 'total' renal, cardiac and splanchnic sympathetic nervous tone in essential hypertension from measurements of noradrenaline release.
    Esler MD; Jennings GL; Johns J; Burke F; Little PJ; Leonard P
    J Hypertens Suppl; 1984 Dec; 2(3):S123-5. PubMed ID: 6599657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenaline release and sympathetic nervous system activity.
    Esler MD; Hasking GJ; Willett IR; Leonard PW; Jennings GL
    J Hypertens; 1985 Apr; 3(2):117-29. PubMed ID: 2991369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-unit muscle sympathetic nervous activity and its relation to cardiac noradrenaline spillover.
    Lambert EA; Schlaich MP; Dawood T; Sari C; Chopra R; Barton DA; Kaye DM; Elam M; Esler MD; Lambert GW
    J Physiol; 2011 May; 589(Pt 10):2597-605. PubMed ID: 21486790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation in the effects of the angiotensin II receptor blocker class on autonomic function.
    Esler M
    J Hypertens Suppl; 2002 Jun; 20(5):S13-9. PubMed ID: 12184059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.